[1]
T. T. Hậu and Đào M. Thế, “29. The clinical, subclinical, and the efficacy of first-line chemotherapy in stage IV non-small cell lung cancer patients harboring EGFREGFR exon 20 insertions”, TCNCYH, vol. 169, no. 8, pp. 242-250, Sep. 2023.